US FDA Declines to Approve Ascendis Hormone Disorder Therapy

May 1 Reuters Ascendis Pharma AS said on Monday the U.S. Food Drug Administration had declined to approve the Danish drugmaker39;s experimental therapy to treat adult patients with a hormone disorder called hypoparathyroidism, citing concerns linked to manufacturing control of the drug and device combination. The company39;s U.S.listed shares surged 19 in premarket trade as the […]
Read More